Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.
Novo’s New Obesity Drug Is Targeting the Most Dramatic Weight Loss Yet
The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a red-hot market hinges on it.
New weight loss drug decreases appetite without nausea — and can even burn calories
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie burning — without any signs of nausea.
Breakthrough May Lead to New Weight Loss Drugs
Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea or loss of muscle mass
New study suggests weight loss drugs like Ozempic could help with knee pain. Here’s why there may be a link
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and osteoarthritis.
Dr. Sanjay Gupta explains the side effects of weight loss medications
From constipation to muscle loss, the side effects of some weight loss and diabetes medications can be daunting to patients. CNN’s Dr. Sanjay Gupta looks at why these effects occur, and gives some tips on how to keep them in check.
Do Weight Loss Drugs Like Ozempic Affect Your Breast Health?
Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves dealing with an unexpected issue, what's become known as "Ozempic breasts." This possible side effect of glucagon-like peptide 1 (GLP-1) agonist medication users like Ozempic,
Hosted on MSN
3d
Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%.
Novo Nordisk is working on a
new obesity drug
that could help patients shed more than any other weight-loss
drug
on the ...
BioPharma Dive
1d
Metsera raises $215M to accelerate obesity drug plans
With promising Phase 1 results in hand, Metsera hopes to develop a longer-lasting GLP-1 injection along with other types of ...
STAT
16h
Amgen defends obesity drug amid bone concerns
After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...
1d
on MSN
Obesity-fighting drugs may reduce alcohol consumption in individuals with alcohol use disorder
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...
News Medical on MSN
3h
Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes
Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...
MedPage Today on MSN
3d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
STAT
1d
BioNTech acquires its Chinese cancer drug partner
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
3d
New rare disease drugs firm Oranda seeks to raise up to €35m
A new Dublin-headquartered company for rare diseases, Oranda Therapeutics, is seeking to raise €35 million in an early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback